Chronic Myeloid Leukemia
Chronic Myeloid Leukemia (CML) is a type of cancer that affects the white blood cells in the bone marrow. It is caused by an abnormality in a specific gene that produces a protein called BCR-ABL, which causes the healthy white blood cells to grow and divide uncontrollably. CML can cause a range of symptoms including fatigue, weight loss, abdominal pain, and easy bruising or bleeding. Without treatment, CML progresses from an early stage to an advanced stage, which can be fatal. Treatment for CML usually involves medication, such as tyrosine kinase inhibitors, that targets the abnormal gene and helps to slow the production of abnormal white blood cells. In some cases, stem cell transplantation may be necessary. With proper treatment and monitoring, CML can be managed and many people with the disease live long and healthy lives.
← Journal of Advances in Leukemia